Power J. Duncan Smith - 06 Nov 2026 Form 4 Insider Report for Sinclair, Inc. (SBGI)

SEC form
4
Accepted by SEC
10 Nov 2026, 19:44:27 UTC
Prior SEC filing
25 Sep 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Power J. Duncan Smith filed Form 4 for Sinclair, Inc. (SBGI) on 10 Nov 2026.

Key facts

  • This page summarizes Power J. Duncan Smith's Form 4 filing for Sinclair, Inc. (SBGI).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Nov 2026, 19:44.

Change

  • Previous filing in this sequence was filed on 25 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001254011 Primary reporting owner

SMITH J DUNCAN

Relationship
Vice President/Secretary, Director, 10%+ Owner

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBGI transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares
+99,290
Change %
+53670%
Price
$0.000000*
Shares after
99,475
Date
06 Nov 2026
Ownership
Direct
Footnotes
F1, F3, F5
SBGI transaction

Class A Common Stock

Gift

Transaction value
Shares
-35,715
Change %
-36%
Price
$13.70*
Shares after
63,760
Date
06 Nov 2026
Ownership
Direct
Footnotes
F3, F5, F6
SBGI transaction

Class A Common Stock

Gift

Transaction value
Shares
-27,860
Change %
-44%
Price
$13.70*
Shares after
35,900
Date
06 Nov 2026
Ownership
Direct
Footnotes
F3, F5, F6
SBGI transaction

Class A Common Stock

Gift

Transaction value
Shares
-35,715
Change %
-99%
Price
$13.70*
Shares after
185
Date
06 Nov 2026
Ownership
Direct
Footnotes
F3, F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SBGI transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares
-99,290
Change %
-1.8%
Price
$0.000000*
Shares after
5,416,096
Date
06 Nov 2026
Ownership
Direct
Underlying class
Class B Common Stock
Underlying amount
99,290
Exercise price
$0.000000
Footnotes
F1, F2, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents the voluntary conversion of 99,290 shares of Class B Common Stock into 99,290 shares of Class A Common Stock on a one-for-one basis pursuant to the Company's governing documents. No additional consideration was paid in connection with the conversion.

Footnote F2

The Class B Common Stock is convertible at the Reporting Person's election and has no expiration date.

Footnote F3

The Reporting Person also directly owns 22,686.911454 shares of Class A Common Stock held in a 40l(k) unitized stock fund. The Reporting Person also indirectly owns (i) 137,154 shares of Class B Common Stock divided equally among three irrevocable trusts, each for the benefit of a child of the Reporting Person, of which the Reporting Person is a co-trustee; (ii) 41,050 shares of Class B Common Stock held in irrevocable trust f/b/o family members; and (iii) 872,600 shares of Class B Common Stock collectively held in two separate irrevocable trusts f/b/o the Reporting Person.

Footnote F4

The Reporting Person directly owns 185 shares of Class A Common Stock.

Footnote F5

After giving effect to all of the transactions reported on this Form 4, Reporting Person shall own 185 shares of Class A Common Stock.

Footnote F6

Reflects the average closing price on the date of the transactions.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .